NDC 51311-034 - AYRADIA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51311-034
- Package NDCs from labels
- 51311-034-30, 51311-034-10
- Manufacturer
- Virbac AH Inc
- Effective date
- 2023-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AYRADIA - Virbac AH Inc | Virbac AH Inc | 2023-10-26 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51311-034-10 | AYRADIA | 100 mL in 1 BOTTLE | SOLUTION | 100 | 1 | |
| 51311-034-10 | AYRADIA | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 51311-034-30 | AYRADIA | 1 in 1 CARTON | SOLUTION | 1 | 1 | |
| 51311-034-30 | AYRADIA | 30 mL in 1 BOTTLE | SOLUTION | 30 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LIKMEZ | METRONIDAZOLE ORAL | Kesin Pharma Corporation | 23927a8b-1641-4104-aa85-d7b7bf4ebb9d | 2024-12-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | a860b097-7447-a3b7-e053-2995a90a4bfd | 2024-12-26 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Quality Care Products LLC | 0d8125d6-173f-4498-85a9-a1323c7a0e42 | 2024-12-17 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Viona Pharmaceuticals Inc | 93299502-6cb0-48a4-8190-50fef74bdbee | 2024-12-06 | Adverse reactions | 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE | Prasco Laboratories | a6ce81f5-a5c6-44d7-b5f0-61d0530345bd | 2024-11-07 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | e1e7e127-e99e-80e9-1606-71261658b0c1 | 2024-11-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 2fa14353-45df-429c-8759-7d66a65f08f0 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE | Mayne Pharma Inc. | 567c7c0c-ffc1-47c1-b0fb-8715bf3d76b9 | 2024-10-31 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Mayne Pharma Inc. | 3c25a3f9-52fc-448e-a044-f63b9dadcd4a | 2024-10-31 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 8522493d-0a18-49dd-8d49-bd159f6ee332 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 92e58420-1d99-4a92-b1f3-a7f791ca7187 | 2024-10-31 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | e6ece591-38fa-4016-bd62-d31a3e5a8da3 | 2024-10-21 | Warnings, Adverse reactions | 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE | Aurobindo Pharma Limited | d9d4caed-2fa9-4b46-9b7c-d60ec3b879b2 | 2024-10-17 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | daee5e69-aa86-470b-81b7-3074d27fc847 | 2024-10-08 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Mayne Pharma Inc. | 5099691f-f216-4ac1-b057-99a845cc770f | 2024-09-30 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Rising Pharma Holdings, Inc. | 93e4f174-4fe0-4cfd-a0cf-d0963e082107 | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 8e1f507b-22fa-4033-9b3e-5435f20ace66 | 2024-09-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Aurobindo Pharma Limited | f68397ee-67db-472e-8607-4300064e37df | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | Viona Pharmaceuticals Inc | 0f108035-d2ab-49c1-9f8d-daae11f0efe0 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| METRONIDAZOLE | METRONIDAZOLE | Zydus Lifesciences Limited | f3ef765c-b531-4aaa-a86d-e32b7254ca48 | 2024-08-13 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.